Module 2 - Recognizing and Assessing CRS in the ED
Primary Audience:
This activity is intended to meet the educational needs of emergency department clinicians.
In this module we’ll delve deeper into how to identify CRS: understanding risk factors, working up patients, and applying grading scales.
Syed Abbas Ali, MBBS
Assistant Professor or Oncology
Department of Oncology, Hematologic Malignancies
Johns Hopkins School of Medicine
Baltimore, MD
Dr. Syed Abbas Ali is a medical oncology specialist in Baltimore, caring for patients with cancer.
Dr. Ali earned his M.B.B.S. at The Aga Khan University. He completed his residency at the University of Arkansas for Medical Sciences and performed a fellowship in medical oncology at the National Institutes of Health.
1.
Apply guideline recommendations and expert opinion to the identification of bispecific antibody and CAR T-cell therapy-related CRS in the emergency setting.
